NEWBRY Stock Chart & Stats
kr2.35
kr0.00(0.00%)
At close: 4:00 PM EST
kr2.35
kr0.00(0.00%)
Day’s Range― - ―
52-Week Rangekr0.76 - kr7.88
Previous CloseN/A
Volume51.00
Average Volume (3M)72.83K
Market Cap
kr79.03M
Enterprise Valuekr36.14M
Total Cash (Recent Filing)kr12.86M
Total Debt (Recent Filing)kr0.00
Price to Earnings (P/E)―
Beta0.39
Next Earnings
Oct 28, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.59
Shares Outstanding30,397,888
10 Day Avg. Volume105,199
30 Day Avg. Volume72,835
Financial Highlights & Ratios
PEG Ratio0.16
Price to Book (P/B)1.36
Price to Sales (P/S)1.92
P/FCF Ratio-2.65
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
NEWBRY FAQ
What was Newbury Pharmaceuticals AB’s price range in the past 12 months?
Newbury Pharmaceuticals AB lowest stock price was kr0.76 and its highest was kr7.88 in the past 12 months.
What is Newbury Pharmaceuticals AB’s market cap?
Newbury Pharmaceuticals AB’s market cap is kr79.03M.
When is Newbury Pharmaceuticals AB’s upcoming earnings report date?
Newbury Pharmaceuticals AB’s upcoming earnings report date is Oct 28, 2026 which is in 95 days.
How were Newbury Pharmaceuticals AB’s earnings last quarter?
Currently, no data Available
Is Newbury Pharmaceuticals AB overvalued?
According to Wall Street analysts Newbury Pharmaceuticals AB’s price is currently Overvalued.
Does Newbury Pharmaceuticals AB pay dividends?
Newbury Pharmaceuticals AB does not currently pay dividends.
What is Newbury Pharmaceuticals AB’s EPS estimate?
Newbury Pharmaceuticals AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Newbury Pharmaceuticals AB have?
Newbury Pharmaceuticals AB has 30,397,888 shares outstanding.
What happened to Newbury Pharmaceuticals AB’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Newbury Pharmaceuticals AB?
Currently, no hedge funds are holding shares in SE:NEWBRY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Newbury Pharmaceuticals AB
Newbury Pharmaceuticals AB (publ), a hybrid pharmaceutical enterprise, serves both the Swedish and wider Scandinavian markets. Formed in 2020 and headquartered in Lund, Sweden, the company provides a variety of therapeutic solutions, with a strong emphasis on oncology, rare diseases, and neurology, in addition to other treatment categories.